Similar articles

• Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.

  Pratt CB, Simone JV, Zee P, Aur RJ, Johnson WW. Pratt CB, et al. J Pediatr. 1970 Sep;77(3):474-83. doi: 10.1016/s0022-3476(70)80023-3. J Pediatr. 1970. PMID: 5278225 Clinical Trial. No abstract available.
• Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.

  Jaffe N, Traggis D, Das L, Kim BS, Won H, Hann L, Moloney WC, Dohlwitz A. Jaffe N, et al. Pediatrics. 1972 Apr;49(4):590-5. Pediatrics. 1972. PMID: 4501679 No abstract available.
• [Apropos of certain toxic effects of L-asparaginase in human therapy].

  Oberling F, Cazenave JP, Lang JM, Kurtz D, Mayer G, Waitz R. Oberling F, et al. Sem Hop. 1971 May 8;47(22):1421-5. Sem Hop. 1971. PMID: 4326093 French. No abstract available.
• L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms.

  Haskell CM. Haskell CM. Cancer Treat Rep. 1981;65 Suppl 4:57-9. Cancer Treat Rep. 1981. PMID: 7049381 Review.
• Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.

  Earl M. Earl M. Clin Adv Hematol Oncol. 2009 Sep;7(9):600-6. Clin Adv Hematol Oncol. 2009. PMID: 20020672 Review.